financetom
Business
financetom
/
Business
/
NY Court of Appeals Upholds Uber Arbitration Requirements
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NY Court of Appeals Upholds Uber Arbitration Requirements
Nov 25, 2024 11:07 AM

01:31 PM EST, 11/25/2024 (MT Newswires) -- The State of New York Court of Appeals on Monday upheld a lower court ruling that users who signed Uber Technologies' ( UBER ) updated terms of service in 2021 agreed to arbitrate any disputes with the company.

"For essentially as long as there have been written contracts, parties have entered them without first carefully reviewing their terms," Judge Anthony Cannataro said in his opinion. "That failure can have legal consequences, whether the party is a sophisticated entity or an ordinary consumer, and whether the contract is presented on paper or through an electronic pop-up window."

"Here, the consequence of plaintiff's purported failure to carefully review Uber's ( UBER ) updated terms of use is that she must make her arguments regarding Uber's ( UBER ) allegedly deceptive and unconscionable conduct to a neutral arbitrator, not the courts," Cannataro said.

Uber ( UBER ) did not immediately reply to a request for comment from MT Newswires.

Price: 73.06, Change: +1.55, Percent Change: +2.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Astronics Q3 sales miss estimates
Astronics Q3 sales miss estimates
Nov 4, 2025
Overview * Astronics ( ATRO ) Q3 sales up 3.8% to $211.4 mln, missing analyst expectations * Company reports Q3 net loss of $11.1 mln due to refinancing-related charges * Adjusted EBITDA for Q3 was $32.7 mln, or 15.5% of sales Outlook * Company expects Q4 revenue between $225 mln and $235 mln * Astronics ( ATRO ) sees 2025...
Amgen profit beats estimates, weight-loss data due by year-end
Amgen profit beats estimates, weight-loss data due by year-end
Nov 4, 2025
Nov 4 (Reuters) - Amgen ( AMGN ) on Tuesday reported quarterly financial results that beat Wall Street expectations as product sales rose 12%, offsetting higher operating expenses related to experimental weight-loss drug MariTide and a higher tax rate. The California-based biotech company's third-quarter revenue also rose 12% from a year earlier to $9.56 billion. Adjusted earnings per share increased...
Infleqtion and Churchill Capital Corp X Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination
Infleqtion and Churchill Capital Corp X Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination
Nov 4, 2025
BOULDER, Colo. & NEW YORK--(BUSINESS WIRE)-- Infleqtion, a global leader in neutral-atom–based quantum technology, and Churchill Capital Corp X ( CCCX ) , a publicly traded special purpose acquisition company, today announced the confidential submission of a draft registration statement on Form S-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) on October 29, 2025. The submission...
Niagen Bioscience Q3 sales beat estimates on strong e-commerce performance 
Niagen Bioscience Q3 sales beat estimates on strong e-commerce performance 
Nov 4, 2025
Overview * Niagen Bioscience ( NAGE ) Q3 net sales rise 33%, beating analyst expectations * Adjusted EBITDA for Q3 increases 120%, reflecting improved operational performance * Company reaffirms full-year net sales growth outlook of 25% to 30% Outlook * Niagen Bioscience ( NAGE ) reaffirms 2025 net sales growth of 25% to 30% y-o-y * Company expects 2025 gross...
Copyright 2023-2026 - www.financetom.com All Rights Reserved